Prostate Cancer VL

Prevalence of Cardiovascular Disease in Patients with Prostate Cancer- Alexander Lyon

Details
The following presentation was made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between the 14th and 16th October. Dr. Alexander Lyon discusses the high cardiovascular events in prostate cancer patients and the GnRH agonists associated with elevated risk of CV events and GnRH antagonists has less toxicity in retrospective analysis. Dr. Lyon...

Point- CounterPoint: Are Novel Biomarkers Ready For Primetime in Routine Detection of Prostate Cancer? -Badrinath Konety

Details
Dr. David Crawford invites Dr. Badrinath Konety to provide a counterpoint discussion on novel biomarkers and their use in detecting prostate cancer. Although, Dr. Konety agrees with the value of biomarkers and that they can be used in addition to PSA tests, he is not sure they are ready for prime time. Dr. Konety proposes key questions on novel biomarkers including their level improvement, are the...

Point - CounterPoint: Are Novel Biomarkers Ready For Primetime in Routine Detection of Prostate Cancer?- Scott Eggener

Details
Dr. David Crawford invites Dr. Scott Eggener to participate in a point-counter point discussion on novel biomarkers in the detection of prostate cancer. Dr. Eggener lectures includes information on different biomarkers and reviews the data that supports his position that novel biomarkers are ready for prime time. Novel prostate cancer screening biomarkers preserve benefits of screening and dramati...

Effect of DRE on the 4Kscore for Aggressive prostate cancer with Michael Maccini.

Details
Michael Maccini, MD. presenting the "Effect of DRE on the 4Kscore for Aggressive Prostate Cancer" for E. David Crawford's 5 for 5. The 4Kscore is a new test using total PSA, free PSA, intact PSA, and human kallikrein 2 (hk2) combined with age, digital rectal exam (DRE) findings, and prior biopsy status to more accurately predict risk of Gleason score ≥7 on prostate biopsy. Prior studies examining...

Beyond Drugs and Pumps: A New Approach to the Management of Erectile Dysfunction - Kambiz Tajkarimi

Details
Beyond Drugs and Pumps: A New Approach to the Management of Erectile Dysfunction - A State of the Art Lecture providing a Brief Introduction on this subject. Presented by Kambiz Tajkarimi, MD. A complete one hour lecture is available titled: Dr. Tajkarimi earned his B.S in Biology with focus in neuroscience from Saint Louis University (St. Louis, MO) with highest distinction. He obtained his Medic...

Beyond Drugs and Pumps: A New Approach to the Management of Erectile Dysfunction - Kambiz Tajkarimi

Details
A New Approach to the Management of Erectile Dysfunction - beyond drugs and pumps. A State of the Art Lecture providing depth on the subject. Presented by: Kambiz Tajkarimi, MD. (1 - hour). Dr. Kambiz Tajkarimi earned his B.S in Biology with focus in neuroscience from Saint Louis University (St. Louis, MO) with highest distinction. He obtained his Medical degree from Ponce School of Medicine in Pu...

Prostate Cancer: The Year in Review - Fred Saad

Details
Fred Saad, MD FRCS, presents the Year in Review for Prostate Cancer 2015 as presented at the ASCO GU 2016. Fred Saad MD FRCS, is Full Professor and Chief of Urology and Director of G-U Oncology at the University of Montreal Hospital Centers (CHUM). He holds the U of M Endowed Chair in Prostate Cancer Research and is Director of the molecular oncology research lab in Prostate Cancer. He is the past...

Hydrogel Spacer Prospective Pivotal Trial - Neil Mariados

Details
Neil Mariados - Journal Club Review: Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy STUDY SUMMARY: Prostate radiation therapy rectal toxicity is largely due to the prostate-rectum proximity. A randomized, controlled, multicente...

A Novel Live Cell Microfluidic Diagnostic For Prostate Cancer Risk Stratification - David Albala

Details
A Novel Live Cell Microfluidic Diagnostic For Prostate Cancer Risk Stratification - Data Reviewed Poster available HERE . David M. Albala, M.D. Board Certified Urologist Medical Director, Co-Director of Research Fellowship-trained in Endourology, Laparoscopy and Robotic Surgery Dr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medi...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe